Quick Links
Resources
About MyParkinsonsTeam
Powered By
Below is a listing of treatments and therapies for Parkinson's disease. Click on one to read more information or connect with others currently using it.
Overview
Apokyn is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2004 to treat intermittent “off” episodes in people with advanced Parkinson’s disease. Apokyn is also referred to by its… read more
Overview
Azilect is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2006 to treat motor symptoms in people with Parkinson’s disease. Azilect may be prescribed as a monotherapy to people… read more
Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for Parkinson’s disease or Parkinsonism. Eligibility may be based on specifics of your condition, such… read more
Overview
Cogentin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in all forms of parkinsonism. Cogentin is often prescribed to younger people with Parkinson’s… read more
Overview
Comtan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose effectiveness in treating motor symptoms… read more
Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…
Overview
People with Parkinson’s Disease whose motor symptoms are debilitating and cannot be controlled with medications, or whose side effects from medications are severe, may be candidates for Deep Brain Stimulation… read more
Overview
Duopa is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat fluctuating motor symptoms in those with advanced Parkinson’s Disease. Duopa may be prescribed if your condition… read more
Overview
Eldepryl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1989 to treat motor symptoms in people with Parkinson’s disease. Eldepryl may be prescribed as a monotherapy to people… read more
Overview
Exelon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2000 to treat mild to moderate dementia in people with Parkinson’s disease. Exelon may also be prescribed to treat… read more
Overview
Exercise can help everyone stay healthy and feel their best. For people with Parkinson’s, exercise offers important additional benefits. Getting regular exercise can reduce motor symptoms of Parkinson’s, slow… read more
Overview
Gocovri is a prescription drug approved by the U.S.Food and Drug Administration (FDA) to treat dyskinesia (movement disorder) in people with Parkinson’s disease who are also receiving levodopa-based therapy.… read more
Overview
Inbrija is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat “off” episodes in people with Parkinson’s disease (PD) who are taking oral levodopa/carbidopa.
Inbrija is an… read more
Overview
Kynmobi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for acute, intermittent treatment of “off” episodes in people with Parkinson’s disease. Kynmobi is also referred to by… read more
Overview
Together, Levodopa and Carbidopa form a combination prescription drug originally approved by the Food and Drug Administration (FDA) in 1975. Levodopa/Carbidopa is used to treat motor symptoms of Parkinsonism… read more
Overview
Some people with Parkinson’s use medical marijuana as a complementary therapy to treat symptoms including pain, mood problems, and sleep disorders.
It is vital to inform your doctor of all treatments you… read more
The Mirapex brand name has been discontinued in the U.S. Generic alternatives may be available.
Overview
Mirapex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1997 to treat motor…
read moreThe Mirapex ER brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.
Overview
Mirapex ER is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in…
read moreOverview
Neupro is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2007 to treat motor symptoms of Parkinson’s disease. Neupro is also referred to by its drug name, rotigotine.
Neupro… read more
Overview
Northera is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat orthostatic hypotension (dizziness upon standing up) in people with Parkinson’s disease. Northera is also… read more
Overview
Nourianz is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with Parkinson’s experiencing “off” episodes. Nourianz is also referred to by its drug name, istradefylline.… read more
Overview
Nuplazid is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease. Nuplazid is also known by its drug… read more
Overview
Like everyone else, people with Parkinson’s feel their best when they consistently eat a healthy, balanced diet. There is no specific diet for Parkinson’s, but following certain guidelines can ensure that your… read more
Overview
Onapgo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. It is prescribed to individuals who experience “off”…
Overview
Ongentys is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with Parkinson’s experiencing “off” episodes. Ongentys is also referred to by its drug name, opicapone.… read more
Overview
Osmolex ER is an extended-release formulation of amantadine that is approved by the U.S. Food and Drug Administration (FDA) to treat symptoms of Parkinson’s disease, such as stiffness, tremors, and shaking. It is…
Overview
Parcopa is a prescription drug approved by the Food and Drug Administration (FDA) in 2004 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or… read more
Overview
Parlodel is a prescription drug approved by the Food and Drug Administration (FDA) to treat the symptoms of Parkinson’s. Parlodel is also indicated to treat acromegaly, as well as problems associated with… read more
The Requip brand name has been discontinued in the U.S. Generic alternatives may be available.
Overview
Requip is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1997 to treat motor symptoms…
read moreOverview
Rytary is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or… read more
Overview
Selegiline is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in people with Parkinson’s disease. Selegiline may be prescribed as a monotherapy to people with… read more
Overview
Seroquel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. Seroquel is also known by its drug name, quetiapine. Seroquel is sometimes prescribed… read more
Overview
Sinemet is a prescription drug approved by the Food and Drug Administration (FDA) in 1975 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or… read more
Overview
Stalevo is a prescription drug approved by the Food and Drug Administration (FDA) in 2003 to treat motor symptoms of Parkinson’s Disease. Stalevo is often prescribed in cases of advanced Parkinson’s Disease… read more
The Symmetrel brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.
Overview
Symmetrel is a prescription medication approved by the Food and Drug Administration (FDA) in…
read moreOverview
Tasmar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1998. Tasmar is prescribed as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose… read more
Overview
Trihexyphenidyl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in all forms of parkinsonism. Trihexyphenidyl is often prescribed to younger people with… read more
Overview
Vyalev is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. This treatment is intended for individuals who experience…
Overview
Xadago is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an add-on medication to treat Parkinson’s disease. Xadago is indicated for people who are taking levodopa/carbidopa but… read more
Overview
Zelapar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in people with Parkinson’s disease. Zelapar may be prescribed as a monotherapy to people with early… read more
Sign up for free!
Join
Your privacy is our priority.